Success Metrics

Clinical Success Rate
50.0%

Based on 1 completed trials

Completion Rate
50%(1/2)
Active Trials
0(0%)
Results Posted
200%(2 trials)
Terminated
1(33%)

Phase Distribution

Ph not_applicable
3
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

50.0%

1 of 2 finished

Non-Completion Rate

50.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Completed(1)
Terminated(1)
Other(1)

Detailed Status

unknown1
Completed1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
50.0%
Most Advanced
N/A

Trials by Phase

N/A3 (100.0%)

Trials by Status

unknown133%
completed133%
terminated133%

Recent Activity

0 active trials
Showing 3 of 3
completednot_applicable

Micropulse for Suppression of Diabetic Macular Edema

NCT03519581
terminatednot_applicable

Study on the Use of Micropulse Laser to Treat Central Serous Chorioretinopathy

NCT01982383
unknownnot_applicable

Comparison Between Treatment With Yellow Micropulse Laser and Green Conventional Laser in Diabetic Macular Edema

NCT01928654

Clinical Trials (3)

Showing 3 of 3 trials
NCT03519581Not Applicable

Micropulse for Suppression of Diabetic Macular Edema

Completed
NCT01982383Not Applicable

Study on the Use of Micropulse Laser to Treat Central Serous Chorioretinopathy

Terminated
NCT01928654Not Applicable

Comparison Between Treatment With Yellow Micropulse Laser and Green Conventional Laser in Diabetic Macular Edema

Unknown

All 3 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
3